These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
4134 related items for PubMed ID: 8895366
1. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. van Haarst AD, Oitzl MS, Workel JO, de Kloet ER. Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366 [Abstract] [Full Text] [Related]
2. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER. Psychoneuroendocrinology; 1995 Nov; 20(6):655-75. PubMed ID: 8584606 [Abstract] [Full Text] [Related]
3. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Spencer RL, Kim PJ, Kalman BA, Cole MA. Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777 [Abstract] [Full Text] [Related]
4. Effect of the glucocorticoid receptor antagonist Org 34850 on basal and stress-induced corticosterone secretion. Spiga F, Harrison LR, Wood SA, Atkinson HC, MacSweeney CP, Thomson F, Craighead M, Grassie M, Lightman SL. J Neuroendocrinol; 2007 Nov; 19(11):891-900. PubMed ID: 17927667 [Abstract] [Full Text] [Related]
5. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Bradbury MJ, Akana SF, Dallman MF. Endocrinology; 1994 Mar; 134(3):1286-96. PubMed ID: 8119168 [Abstract] [Full Text] [Related]
8. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats. Huang TS. J Endocrinol Invest; 1997 Mar; 20(7):393-6. PubMed ID: 9309537 [Abstract] [Full Text] [Related]
9. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA. J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536 [Abstract] [Full Text] [Related]
15. Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat. Steiner MA, Sciarretta C, Brisbare-Roch C, Strasser DS, Studer R, Jenck F. Psychoneuroendocrinology; 2013 Apr; 38(4):560-71. PubMed ID: 22917622 [Abstract] [Full Text] [Related]
16. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP. Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652 [Abstract] [Full Text] [Related]
17. Ontogeny of gender-specific responsiveness to stress and glucocorticoids in the rat and its determination by the neonatal gonadal steroid environment. Patchev VK, Hayashi S, Orikasa C, Almeida OF. Stress; 1999 Aug; 3(1):41-54. PubMed ID: 19016192 [Abstract] [Full Text] [Related]